{"id":"https://openalex.org/W2017573285","doi":"https://doi.org/10.1007/s10198-011-0335-x","title":"Cost effectiveness of golimumab for the treatment of active psoriatic arthritis","display_name":"Cost effectiveness of golimumab for the treatment of active psoriatic arthritis","publication_year":2011,"publication_date":"2011-06-30","ids":{"openalex":"https://openalex.org/W2017573285","doi":"https://doi.org/10.1007/s10198-011-0335-x","mag":"2017573285","pmid":"https://pubmed.ncbi.nlm.nih.gov/21720868"},"language":"en","primary_location":{"id":"doi:10.1007/s10198-011-0335-x","doi":"https://doi.org/10.1007/s10198-011-0335-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10198-011-0335-x","pdf_url":null,"source":{"id":"https://openalex.org/S16530434","display_name":"The European Journal of Health Economics","issn_l":"1439-3972","issn":["1439-3972","1439-6637","1618-7598","1618-7601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","fnege-3","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The European Journal of Health Economics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103595191","display_name":"Ewen Cummins","orcid":"https://orcid.org/0009-0009-1803-4456","observed_orcids":["https://orcid.org/0009-0009-1803-4456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ewen Cummins","raw_affiliation_strings":["McMaster Development Consultants Ltd, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McMaster Development Consultants Ltd, Glasgow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082515232","display_name":"Christian Asseburg","orcid":"https://orcid.org/0000-0001-7196-3363","observed_orcids":["https://orcid.org/0000-0001-7196-3363"]},"institutions":[{"id":"https://openalex.org/I4210124525","display_name":"ESiOR Oy (Finland)","ror":"https://ror.org/02eeq5d55","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124525"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Christian Asseburg","raw_affiliation_strings":["ESiOR Oy, Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ESiOR Oy, Kuopio, Finland","institution_ids":["https://openalex.org/I4210124525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018094344","display_name":"Manishi Prasad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manishi Prasad","raw_affiliation_strings":["Schering-Plough Ltd, Kenilworth, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Ltd, Kenilworth, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113877419","display_name":"Jacqueline Buchanan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacqueline Buchanan","raw_affiliation_strings":["Buchanan Biotech Consultants, Mountain View, CA, USA","Buchanan Biotech Consultants, Mountain View, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Buchanan Biotech Consultants, Mountain View, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Buchanan Biotech Consultants, Mountain View, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030471784","display_name":"Yogesh Suresh Punekar","orcid":"https://orcid.org/0000-0002-7531-1319","observed_orcids":["https://orcid.org/0000-0002-7531-1319"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yogesh Suresh Punekar","raw_affiliation_strings":["Schering-Plough Ltd, Welwyn Garden City, AL7 1TW, UK","Schering\u2010Plough Ltd, Welwyn Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Ltd, Welwyn Garden City, AL7 1TW, UK","institution_ids":[]},{"raw_affiliation_string":"Schering\u2010Plough Ltd, Welwyn Garden City, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030471784"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.6174,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.81872522,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"6","first_page":"801","last_page":"809"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.032499998807907104,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/golimumab","display_name":"golimumab","score":1.0},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.8119999766349792},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9629999995231628},{"id":"https://openalex.org/keywords/health-assessment-questionnaire","display_name":"Health Assessment Questionnaire","score":0.7080000042915344},{"id":"https://openalex.org/keywords/psoriasis-area-severity-index","display_name":"Psoriasis Area Severity Index","score":0.9399999976158142},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.5040000081062317},{"id":"https://openalex.org/keywords/subcutaneous-biologic-therapy","display_name":"subcutaneous biologic therapy","score":0.699999988079071},{"id":"https://openalex.org/keywords/national-health-service","display_name":"National Health Service","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.9807783961296082},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.9392496347427368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5686249732971191},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.37764087319374084},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3549373149871826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.251348614692688},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.15884649753570557},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.07151180505752563}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s10198-011-0335-x","doi":"https://doi.org/10.1007/s10198-011-0335-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10198-011-0335-x","pdf_url":null,"source":{"id":"https://openalex.org/S16530434","display_name":"The European Journal of Health Economics","issn_l":"1439-3972","issn":["1439-3972","1439-6637","1618-7598","1618-7601"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","fnege-3","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The European Journal of Health Economics","raw_type":"journal-article"},{"id":"pmid:21720868","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21720868","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The European journal of health economics : HEPAC : health economics in prevention and care","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:eujhec:v:13:y:2012:i:6:p:801-809","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10.1007/s10198-011-0335-x","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W104178174","https://openalex.org/W1599887951","https://openalex.org/W1922300671","https://openalex.org/W1922566561","https://openalex.org/W1973201198","https://openalex.org/W1975164223","https://openalex.org/W1980536183","https://openalex.org/W2020401428","https://openalex.org/W2045317929","https://openalex.org/W2061911339","https://openalex.org/W2071291145","https://openalex.org/W2094124191","https://openalex.org/W2099706116","https://openalex.org/W2100222785","https://openalex.org/W2101695974","https://openalex.org/W2109268320","https://openalex.org/W2121025314","https://openalex.org/W2133696182","https://openalex.org/W2139788459","https://openalex.org/W2145412985","https://openalex.org/W2145778588","https://openalex.org/W2149168537","https://openalex.org/W2156796142","https://openalex.org/W2168698481","https://openalex.org/W2417907140"],"related_works":["https://openalex.org/W2757228504","https://openalex.org/W2061911339","https://openalex.org/W2135253065","https://openalex.org/W2804271470","https://openalex.org/W2121025314","https://openalex.org/W7128374830","https://openalex.org/W2798103542","https://openalex.org/W2144702115","https://openalex.org/W2049771114","https://openalex.org/W2154721856"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}